In this article, we will discuss the 10 Cheap Robotics Stocks to Buy Right Now.
The robotics industry has been on a roll amid a wave of unprecedented commercial breakthroughs, regulatory milestones, and an influx of venture capital. Investor sentiment in the industry has improved significantly, with the ROBO Global Robotics and Automation Index ETF is already up about 28%, outpacing the S&P 500, which is up about 9% over the same period.
The outperformance comes against the backdrop of robots and automated systems taking over almost all industries, from surgical suites to factory floors and essential infrastructure, while presenting compelling investment opportunities. At the CES 2026 conference, Jensen Huang reiterated that the moment of robotics is here.
“The ChatGPT moment for robotics is here. Breakthroughs in physical AI — models that understand the real world, reason and plan actions — are unlocking entirely new applications,” said Jensen Huang, founder and CEO of NVIDIA.
Huang’s sentiments follow the International Federation of Robotics, reiterating that the global industrial robot installations reached an all-time high of $16.7 billion. Similarly, global robotics funding rose to an all-time high of $10.3 billion in 2025. The global robotics market is projected to reach $124.37 billion, affirming long-term investor conviction.
With that in mind, let’s take a look at some cheap robotics stocks to buy right now, poised to capitalize on the sector’s growth momentum.
Our Methodology
To compile a list of the cheap robotics stocks to buy right now, we used Finviz and Yahoo Screener to scan for robotics stocks across various industries. We also analyzed robotics ETFs and settled on cheap stocks trading at a forward price to earnings multiple of less than 20. We further trimmed the list by focusing on stocks with an upside potential of more than 15%. These stocks are also popular among elite hedge funds in Q1 2026. Finally, we ranked the stocks based on the number of hedge funds holding stakes in them.
Some companies on this list are not pure-play robotics manufacturers but are included because they provide robotics-enabling technologies, automation platforms, industrial AI systems, surgical robotics, or software solutions that support the broader robotics ecosystem. Valuation metrics were collected from financial data providers at the time of screening and may have changed since due to market movements and analyst estimate revisions.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
Cheap Robotics Stocks to Buy Right Now
10. Zebra Technologies Corporation (NASDAQ:ZBRA)
Stock Upside Potential: 27.67%
Forward P/E: 12.05
Number of Hedge Fund Holders: 36
Zebra Technologies Corporation (NASDAQ:ZBRA) is one of the cheap robotics stocks to buy right now. On May 14, BNP Paribas reiterated an Outperform rating on Zebra Technologies and raised the price target to $370 from $365.
The bullish stance and price target hike come amid the robotics company’s solid first-quarter results, which exceeded expectations. The company also raised its 2026 guidance, even as it faces the prospect of rising memory prices. Net sales in the quarter were up 14.3% to $1.5 billion, while net income came in at $135 million, or $2.72 a share.
Zebra Technologies benefited from a favorable product mix, deal accretion, and the Elo acquisition, as the productivity initiative also helped offset higher memory price headwinds. According to Bill Burns, Chief Executive Officer of Zebra Technologies, the solid first-quarter results underscored the durability of demand for the company’s innovative technology and organic growth across all regions.
For the second quarter, Zebra Technologies expects sales to grow between 14% and 17%, with diluted earnings per share of $4.20 to $4.50.
Zebra Technologies Corporation designs and builds hardware, software, and automation solutions that track, manage, and digitize physical assets. Their technology is used by frontline workers in retail, healthcare, manufacturing, and logistics to streamline workflows and improve operational efficiency.
9. UiPath Inc. (NYSE:PATH)
Stock Upside Potential: 19.47%
Forward P/E: 12.94
Number of Hedge Fund Holders: 40
UiPath Inc. (NYSE:PATH) is one of the cheap robotics stocks to buy right now. On May 12, UiPath Inc. announced plans to make it easier for enterprises to deploy coding agents with built-in orchestration and governance capabilities.
UiPath for Coding Agents is the company’s new platform designed to make it easier for organizations to use coding agents, including Code and OpenAI Codex, to build, test, deploy, and operate automations through natural language conversations. The platform comes with capabilities for connecting coding agents to CI/CD infrastructure, testing frameworks, and governance controls.
The new platform is currently available to enterprise customers, enabling business analytics process owners and domain experts to create automations through conversations. Its unveiling comes on the heels of the company releasing several agentic AI tools through its Automation Suite platform, as it seeks to enhance its automation solutions across various sectors. UiPath’s Purchase-to-Pay solution streamlines procurements and accounts payable operations, reducing manual processing in purchase-to-pay workflows.
UiPath Inc. specializes in Robotic Process Automation (RPA), which means it builds software robots that act as digital workers rather than physical hardware. These software robots are designed to mimic human-computer interactions to automate repetitive, rule-based, and time-consuming tasks.
8. Emerson Electric Co. (NYSE:EMR)
Stock Upside Potential: 17.97%
Forward P/E: 19.77
Number of Hedge Fund Holders: 43
Emerson Electric Co. (NYSE:EMR) is one of the cheap robotics stocks to buy right now. On May 26, Emerson Electric Co. inked a strategic collaboration with SiMa.ai to integrate SiMa.ai’s MLSoC (Machine Learning System on Chip) technology into Emerson’s industrial PCs.
SiMa.ai’s MLSoCTM (Machine Learning System on Chip) is designed to deliver high-performance computing and power efficiency for Emerson’s industrial PCs, enabling physical AI workloads. It also features an autonomous safety system that detects gas and liquid leaks, enhancing productivity.
The integration of advanced artificial intelligence capabilities into industrial personal computers will enable Emerson to perform real-time data analysis in factory and remote site environments. In return, the systems will be able to operate at temperatures between 40 and 140 degrees Fahrenheit.
Delivering advanced AI capabilities in the harshest industrial field environments is part of Emerson’s bid to pursue opportunities in the Industrial AI market, poised to reach $153.9 billion by 2030, growing at a 23% compound annual growth rate. Part of the growth comes from the growing demand for AI technology at the industrial edge.
Emerson (Emerson Electric Co.) is a global technology and engineering powerhouse that builds hardware, software, and AI-driven solutions that act as the “central nervous system” for major industrial manufacturing facilities.
7. PTC Inc. (NASDAQ:PTC)
Stock Upside Potential: 27.34%
Forward P/E: 16.12
Number of Hedge Fund Holders: 51
PTC Inc. (NASDAQ: PTC) is one of the cheap robotics stocks to buy right now. On May 21, Mazda Motor Corporation selected PTC Inc.’s Codebeamer Application Lifecycle Management solution to support its software-defined vehicle development (SDV).
The automaker is to leverage Codebeamer to standardize requirements testing and validation processes in vehicle development. The platform provides workflows for safety-critical development with checkpoints. It also makes it easier to track connections between Model-Based Development data and validation results.
PTC expects the Codebeamer integration to help Mazda transition to software-defined vehicle development by consolidating dispersed documentation and supporting requirements management and collaboration.
The automaker settled on the platform for its ability to strengthen requirements, improve traceability, and enhance visibility while supporting greater alignment across teams. The strategic partnership aligns with PTC’s vision for the Intelligent Product Lifecycle, which seeks to help manufacturers and product companies build a product data foundation in engineering.
PTC Inc. provides industrial software solutions that help robotics and automation companies design, simulate, build, and manage their robotic systems. Instead of building physical hardware, PTC provides the digital backbone—including CAD, Product Lifecycle Management (PLM), and AI integrations.
6. Globus Medical, Inc. (NYSE:GMED)
Stock Upside Potential: 35.75%
Forward P/E: 16.03
Number of Hedge Fund Holders: 52
Globus Medical, Inc. (NYSE:GMED) is one of the cheap robotics stocks to buy right now. On May 18, Citizens reiterated a Market Perform rating on Globus Medical on first-quarter results exceeding expectations.
The impressive results were characterized by 27% overall revenue growth and record earnings. Organic revenue was up 13%, driven by share gains and procedural volume strength in core spine. Consequently, worldwide revenues totaled $759.9 million, as base business net sales excluding Nevro totaled $677.2 million.
Robust revenue growth came as Globus Medical’s Musculoskeletal Solutions and Enabling Tech segments achieved broad-based growth in the quarter. Revenue in the Spine channel was up 10%, marking the third consecutive quarter of 10% growth. Net income in the quarter totaled $124.3 million as diluted earnings per share increased 64.7% to $1.12.
Earnings beat estimates by 22%, driven by higher sales. International Spine revenue was also up by 10%. For the full year, Globus Medical expects revenue to range between $3.18 billion and $3.33 billion. It has also updated its non-GAAP diluted EPS to between $4.70 and $4.80, up from the previous guidance of $4.40 to $4.50.
Globus Medical, Inc. develops advanced surgical robotics and navigation platforms designed to improve the accuracy, safety, and efficiency of orthopedic, spinal, and cranial procedures. Their technology acts as a “third hand” for surgeons, combining rigid robotic arms with real-time tracking.
5. Aptiv PLC (NYSE:APTV)
Stock Upside Potential: 30.11%
Forward P/E: 9.36
Number of Hedge Fund Holders: 53
Aptiv PLC (NYSE:APTV) is one of the cheap robotics stocks to buy right now. On May 6, UBS reiterated a Buy rating on Aptiv PLC and an $80 price target, buoyed by the company’s solid first-quarter results.
The better-than-expected results came as the company increasingly focuses on enabling devices and systems that sense, think, act, and optimize across all industries. The company delivered a 5% year-over-year increase in revenue to $5.1 billion, driven by 7% growth in North America and 7% growth in South America.
Aptiv PLC also bounced back to profitability, reporting net income of $189 million and earnings per share of $0.88, compared with a net loss of $11 million, or $0.05 a share, delivered in the same quarter last year. For the second quarter, the company expects net sales to range between $3.2 billion and $3.4 billion with net income of between $140 million and $180 million. For the full year, sales are expected to be between $12.8 billion and $13.2 billion, with net income between $830 and $910 million.
According to UBS, Aptiv is well-positioned to meet its guidance and maintain its outlook despite cost pressures. The research firm also sees positive developments in China.
Aptiv PLC is a global technology company that designs, develops, and manufactures hardware and software solutions for the automotive and commercial vehicle industries.
4. Medtronic plc (NYSE:MDT)
Stock upside Potential: 38.04%
Forward P/E: 12.49
Number of Hedge Fund Holders: 60
Medtronic plc (NYSE:MDT) is one of the cheap robotics stocks to buy right now. On May 20, Medtronic PLC (NYSE:MDT) reiterated plans to expand its care options for people struggling with chronic pain with the acquisition of SPR Therapeutics.
The company is poised to pay $650 million to acquire all outstanding equity in SPR, underscoring its focus on deals that enhance its core franchises. The transaction is poised to close in the fall, within the first half of Medtronic’s Fiscal Year 2027, subject to regulatory approvals.
The acquisition will enhance the company’s Neuromodulation portfolio with temporary peripheral nerve stimulation (PNS) technology. Consequently, it will be well equipped to reach and support people with minimally invasive pain-relief options.
Medtronic is to gain access to SPR’s SPRINT System, which provides pain relief without the need for permanent implants. In addition, the acquisition will enable the company to reach more patients with less-invasive pain relief solutions.
“Our purpose first and foremost is to serve patients,” said Domenico De Paolis, Interim President, Neuromodulation, part of the Medtronic Neuroscience Portfolio. “That is why we continue to thoughtfully expand our pain intervention therapies. The addition of temporary peripheral nerve stimulation helps broaden access to neuromodulation and supports patients across more stages of the chronic pain journey with a minimally invasive therapy.”
On March 27, Medtronic received FDA clearance for its Stealth AXiS surgical system for cranial and ENT procedures, following earlier approval for spine. The platform unifies planning, navigation, and robotics into one intelligent system, offering AI‑enabled tractography for brain mapping, real‑time imaging through GE HealthCare’s bkActiv, and advanced visualization tailored to ENT workflows. Designed with flexible architecture to support ongoing innovation, Stealth AXiS reinforces Medtronic’s strategy to deliver connected technologies that enhance precision, efficiency, and surgeon confidence across multiple specialties.
Medtronic plc (NYSE:MDT) develops advanced robotic-assisted surgery (RAS) platforms and AI-driven surgical technologies designed to increase precision, reduce hospital stays, and lower healthcare costs. Their robotics portfolio spans multiple medical specialties, most notably soft-tissue surgery, spine procedures, and cranial care.
3. Stryker Corporation (NYSE:SYK)
Stock Upside Potential: 28.02%
Forward P/E: 18.38
Number of Hedge Fund Holders: 81
Stryker Corporation (NYSE:SYK) is one of the cheap robotics stocks to buy right now. On May 26, Stryker Corporation launched its Pangea Plating System platform in Europe for the treatment of fracture patterns. The launch follows the completion of the first clinical case in Europe.
The Pangea Plating System features non-active implants that provide temporary stabilization of bones or bone fragments. It also features plates and complementary instrumentation that support plate fit, providing surgeons with options for fracture fixation.
The fracture pattern system was developed in collaboration with 26 orthopedic surgeons. It is now part of Stryker’s Pangea portfolio, which incorporates global anatomical data to support plate fixation across patients. Its development underscores the company’s focus and bid in developing solutions that enhance surgical workflow and address evolving needs in trauma care.
Pangea Plating System’s European launch is poised to expand Stryker’s trauma portfolio while underscoring the company’s commitment to supporting fracture fixation in collaboration with orthopedic surgeons worldwide.
In February 2026, Stryker announced the limited release of Mako RPS (Robotic Power System) for Total Knee, a handheld robotic system that combines its robotics and power tool expertise. Compatible with the Triathlon Total Knee System, Mako RPS offers surgeons robotic precision with the familiarity of manual tools, featuring intraoperative planning and an active‑adjustment saw that guides movements in real time.
Building on nearly 20 years of Orthopaedic robotics and over 2 million procedures worldwide, Stryker has expanded the Mako brand to include both Mako SmartRobotics and Mako Handheld Robotics, reinforcing its leadership in advancing patient outcomes.
Stryker Corporation is a leading global medical technology company that manufactures and supplies innovative surgical equipment, medical devices, and implantable products. Their technologies are used by hospitals and healthcare facilities globally to improve patient outcomes and streamline surgical procedures.
2. Johnson & Johnson (NYSE:JNJ)
Stock Upside Potential: 15.47%
Forward P/E: 18.09
Number of Hedge Fund Holders: 113
Johnson & Johnson is one of the cheap robotics stocks to buy right now. On May 12, Johnson & Johnson confirmed the global launch of the Shockwave C2 Aero Coronary IVL Catheter for the treatment of calcified coronary artery disease, as it seeks to redefine the standards of coronary IVL with efficient, predictable procedures.
The next-generation intravascular lithotripsy catheter features enhanced deliverability and lesion-crossing capabilities. It leverages ultrasonic acoustic pressure waves to disrupt calcified plaque in coronary arteries, extending Shockwave IVL’s clinically validated mechanism of action. It also features a flexible shaft balloon and marker brands to enhance navigation in tortuous arteries.
The Shockwave C2 Aero Coronary IVL Catheter enables Johnson & Johnson to target the 315 million people worldwide who are struggling with coronary artery disease. The company has already made the device available in the US and Japan. It also plans to make it available in Europe and Canada.
Earlier on May 5, Johnson & Johnson announced results from the first clinical study of its investigational OTTAVA Robotic Surgical System, showing that in a 30‑patient trial for Roux‑en‑Y gastric bypass all procedures were completed robotically without conversion, meeting safety and performance endpoints and achieving an average 30‑pound weight loss at 30 days.
The data, presented at the 2026 ASMBS Annual Meeting, supported an FDA De Novo application for OTTAVA to cover multiple upper‑abdominal procedures, highlighting its novel table‑integrated design that enables use in space‑constrained operating rooms and reinforces J&J’s commitment to advancing bariatric and general surgery through robotics innovation.
Johnson & Johnson focuses on medical robotics and digital surgery. They are actively developing advanced surgical systems and data ecosystems to improve patient outcomes across general surgery, lung diagnostics, and orthopedics.
1. NVIDIA Corporation (NASDAQ:NVDA)
Stock Upside Potential: 44.97%
Forward P/E: 17.3
Number of Hedge Fund Holders: 275
NVIDIA Corporation (NASDAQ:NVDA) is one of the cheap robotics stocks to buy right now. On May 26, NVIDIA Corporation reported that its Vera CPU met the new CPU requirements for an artificial intelligence factory. Built with fast cores, massive memory bandwidth, and the ability to sustain high performance, the CPU demonstrated sustained high performance when all cores are active.
Consequently, Vera CPU is well-positioned to deliver the throughput factories need to optimize platform power. In addition, it features NVIDIA Olympus CPU cores designed for sequential CPU work underpinning agentic AI, data processing, and orchestration. The CPU is also capable of delivering outstanding performance within the power profile while offering gains across a broad range of workloads.
The competitive edge comes amid Nvidia CEO Jensen Huang’s claim of a $200 billion market for CPUs. The company sees significant long-term demand from China and the US despite the technological tensions. Demand for CPUs is on the rise as companies and businesses gravitate towards agentic AI and the need to perform autonomous functions.
NVIDIA Corporation focuses on building foundational AI platforms, software, and specialized computer chips to enable physical AI. Rather than building physical robots themselves, they provide the hardware and software systems required for robots to see, learn, perceive their surroundings, and make decisions in real time.
READ NEXT: 10 Best Sin Stocks to Buy Now and 8 Best CBD Stocks to Buy Right Now.
Hedge Fund Resource Center